New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - diphenhydramine hydrochloride 50mg - liquid filled capsule - 50 mg - active: diphenhydramine hydrochloride 50mg excipient: brilliant blue fcf gelatin glycerol macrogol 400 opacode white nsp-78-18022 purified water sorbitol - unisom sleepgels are used as a night time sleep aid for the short-management of insomnia.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - carbetocin 100ug; carbetocin 100 µg/ml - solution for injection - 100 mcg - active: carbetocin 100ug excipient: glacial acetic acid sodium chloride water for injection active: carbetocin 100 µg/ml excipient: mannitol methionine sodium hydroxide succinic acid water for injection - duratocin is indicated for the prevention of uterine atony and excessive bleeding following delivery of the infant by elective caesarean section under epidural or spinal anaesthesia.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - carvedilol 12.5mg - tablet - 12.5 mg - active: carvedilol 12.5mg excipient: colloidal silicon dioxide crospovidone iron oxide red iron oxide yellow lactose monohydrate magnesium stearate povidone sucrose - indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - carvedilol 25mg - tablet - 25 mg - active: carvedilol 25mg excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate povidone sucrose - indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - carvedilol 3.125mg;   - tablet - 3.125 mg - active: carvedilol 3.125mg   excipient: colloidal silicon dioxide crospovidone iron oxide red lactose monohydrate magnesium stearate povidone sucrose - indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - carvedilol 6.25mg - tablet - 6.25 mg - active: carvedilol 6.25mg excipient: colloidal silicon dioxide crospovidone iron oxide yellow lactose monohydrate magnesium stearate povidone sucrose - indicated for the management of essential hypertension. it can be used alone or in combination with other antihypertensive agents (e.g. calcium channel blockers, diuretics).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg free base - tablet - 0.1 mg - active: desmopressin acetate trihydrate 0.1mg equivalent to 0.089 mg free base excipient: ethanol lactose monohydrate magnesium stearate potato starch povidone purified water

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - desmopressin acetate trihydrate 0.2mg equivalent to 0.178 mg free base - tablet - 0.2 mg - active: desmopressin acetate trihydrate 0.2mg equivalent to 0.178 mg free base excipient: ethanol lactose monohydrate magnesium stearate potato starch povidone purified water - the treatment of primary nocturnal enuresis in patients (from 5 years of age) with normal ability to concentrate urine.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - tretinoin 10mg - liquid filled capsule - 10 mg - active: tretinoin 10mg excipient: gelatin glycerol iron oxide red iron oxide yellow karion 83 soya bean oil, hydrogenated soya oil   titanium dioxide yellow beeswax - vesanoid should be used for induction of remission in acute promyelocytic leukaemia (apl; fab classification aml-m3). previously untreated patients as well as patients who relapse after or are refractory to standard chemotherapy (anthracycline and cytosine arabinoside or equivalent therapies) may be treated with tretinoin. following complete remission, consolidation full-dosechemotherapy should be employed. the addition of chemotherapy to tretinoin improves the chance of longer survival as this combination reduces the risk of relapse as compared to chemotherapy alone. maintenance therapy is still under investigation, however a loss of responsiveness to tretinoin has been reported among patients maintained on tretinoin alone.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - budesonide 9mg;   - modified release tablet - 9 mg - active: budesonide 9mg   excipient: colloidal silicon dioxide ethanol hyprolose lactose monohydrate lecithin magnesium stearate methacrylic acid copolymer microcrystalline cellulose purified talc stearic acid titanium dioxide triethyl citrate - cortiment prolonged-release tablets are indicated in adults for induction of remission in patients with mild to moderate active ulcerative colitis (uc) where 5-asa treatment is not sufficient or not tolerated.